Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamdi Levent Doğanay

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|November 21, 2021
CoronaVac efficacy data from Turkey - Authors' replyMine Durusu Tanriover, Hamdi Levent Doğanay, Serhat Unal, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 8, 2020
Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infectionSüleyman Sayar, Kemal Kürbüz, Resul Kahraman, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|July 7, 2021
Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in TurkeyFatih Güzelbulut, Pınar Gökçen, Güray Can, et al.
Journal of Viral Hepatitis|February 15, 2021
Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapyFatih Güzelbulut, Pınar Gökçen, Güray Can, et al.
Clinical Rheumatology|November 9, 2020
Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseasesBetül Sözeri, Ferhat Demir, Hafize Emine Sönmez, et al.
International Journal of Surgical Pathology|March 9, 2022
Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known <i>BRCA1</i> and <i>BRCA2</i> Mutations and Comparison with Histopathological FeaturesBegüm Çalım-Gürbüz, İrem Güvendir, Büşra Ünal, et al.
Clinical Rheumatology|May 28, 2020
Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseasesFerhat Demir, Özlem Akgün Doğan, Yasemin Kendir Demirkol, et al.
Turkish Journal of Medical Sciences|March 22, 2023
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infectionMevlüt Tamer Dincer, Necmi Eren, Ahmet Murt, et al.
Lancet (London, England)|July 11, 2021
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyMine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|November 21, 2021
CoronaVac efficacy data from Turkey - Authors' replyMine Durusu Tanriover, Hamdi Levent Doğanay, Serhat Unal, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 8, 2020
Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infectionSüleyman Sayar, Kemal Kürbüz, Resul Kahraman, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|July 7, 2021
Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in TurkeyFatih Güzelbulut, Pınar Gökçen, Güray Can, et al.
Journal of Viral Hepatitis|February 15, 2021
Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapyFatih Güzelbulut, Pınar Gökçen, Güray Can, et al.
Clinical Rheumatology|November 9, 2020
Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseasesBetül Sözeri, Ferhat Demir, Hafize Emine Sönmez, et al.
International Journal of Surgical Pathology|March 9, 2022
Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known <i>BRCA1</i> and <i>BRCA2</i> Mutations and Comparison with Histopathological FeaturesBegüm Çalım-Gürbüz, İrem Güvendir, Büşra Ünal, et al.
Clinical Rheumatology|May 28, 2020
Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseasesFerhat Demir, Özlem Akgün Doğan, Yasemin Kendir Demirkol, et al.
Turkish Journal of Medical Sciences|March 22, 2023
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infectionMevlüt Tamer Dincer, Necmi Eren, Ahmet Murt, et al.
Lancet (London, England)|July 11, 2021
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyMine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, et al.
Pageof 1